Introduction Mosaic chromosomal alterations (mCAs) detected in white blood cells represent
a type of clonal hematopoiesis (CH) that is understudied compared with CH-related somatic …

We investigated autosomal mosaic chromosomal alterations (mCAs) in 10,248 non-small
cell lung cancer (NSCLC) cases and 9,298 cancer-free controls of Chinese ancestry. Mosaic …

Background Mosaic chromosomal alterations (mCAs) detected from blood-derived DNA are
large structural alterations of clonal haematopoietic origin and are associated with various …

To investigate the association between clonal haematopoiesis (CH) and lung cancer risk,
we identified CH mutations in 1 059 lung cancer cases and 899 controls using the blood …

Clonal hematopoiesis (CH) is a phenomenon caused by expansion of white blood cells
descended from a single hematopoietic stem cell. While CH can be associated with …

Clonal hematopoiesis of indeterminate potential (CHIP) and mosaic chromosomal
alterations (mCAs) represent two forms of clonal hematopoiesis where clones bearing …

Introduction Mosaic loss of chromosome Y (mLOY) is the most commonly detectable mosaic
chromosomal event in cancers; however, its underlying relationship with tumorigenesis is …

PURPOSE To prospectively examine the association between clonal hematopoiesis (CH)
and subsequent risk of lung cancer. METHODS Among 200,629 UK Biobank (UKBB) …

Background Mosaic chromosomal alterations (mCAs) are a promising biomarker for
lymphoid malignancies (LMs). mCAs represent a form of clonal hematopoiesis …

Background Understanding the impact of clonal hematopoiesis of indeterminate potential
(CHIP) and mosaic chromosomal alterations (mCAs) on solid tumor risk and mortality can …